Your browser doesn't support javascript.
loading
Survivin as a potential therapeutic target of acetylsalicylic acid in pituitary adenomas.
Németh, Kinga; Szücs, Nikolette; Czirják, Sándor; Reiniger, Lilla; Szabó, Borbála; Barna, Gábor; Karászi, Katalin; Igaz, Péter; Zivkovic, Vladimir; Korbonits, Márta; Patócs, Attila; Butz, Henriett.
Afiliação
  • Németh K; 2nd Department of Medicine, Faculty of Medicine, Semmelweis University, Budapest, Hungary.
  • Szücs N; 2nd Department of Medicine, Faculty of Medicine, Semmelweis University, Budapest, Hungary.
  • Czirják S; National Institute of Clinical Neurosciences, Budapest, Hungary.
  • Reiniger L; 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
  • Szabó B; Department of Laboratory Medicine, Semmelweis University, Budapest, Hungary.
  • Barna G; 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
  • Karászi K; 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
  • Igaz P; 2nd Department of Medicine, Faculty of Medicine, Semmelweis University, Budapest, Hungary.
  • Zivkovic V; MTA-SE Molecular Medicine Research Group, Hungarian Academy of Sciences and Semmelweis University, Budapest, Hungary.
  • Korbonits M; University Clinical Centre, Belgrade, Serbia.
  • Patócs A; Department of Endocrinology, Barts and The London School of Medicine, Queen Mary University of London, London, United Kingdom.
  • Butz H; Department of Laboratory Medicine, Semmelweis University, Budapest, Hungary.
Oncotarget ; 9(49): 29180-29192, 2018 Jun 26.
Article em En | MEDLINE | ID: mdl-30018744

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article